The Peptide Report
The afternoon energy crash isn't a caffeine problem — it's a mineral problem. Inside the quiet shift among Silicon Valley operators toward a three-mineral stack that's redefining executive performance in 2026.
Longevity researchers have quietly converged on a single nutrient pairing — and they're choosing plant-derived formulations over the lanolin-based versions on most shelves. Here's why D3 without K2 may be only half the equation.
Melatonin is quietly losing favor among high performers. A new class of doctor-formulated sleep formulas is reshaping how executives recover, and the shift reveals something important about modern stress.
Inside the quiet shift among Silicon Valley operators away from melatonin and toward a nighttime peptide nasal spray. A look at the science, the sleep architecture problem, and the doctor-formulated answer.
Silicon Valley founders are quietly stacking a new class of mitochondrial-targeting compounds to sustain output without another stimulant. Here's the science behind the SLU-PP-332 conversation — and why it's becoming the executive performance supplement of 2026.
A quiet shift is underway in Silicon Valley morning routines: caffeine is out, mitochondrial support is in. Inside the rise of NAD+ nasal sprays and the biohacking protocol redefining peak performance.
